Trader consensus on a 96.2% probability against a new coronavirus pandemic in 2026 reflects the established endemic circulation of SARS-CoV-2, with global test positivity rates around 3.4% and only moderate public health risk per the WHO's July 2026 assessment. Surveillance shows seasonal summer waves in regions like the US and China driven by variants such as NB.1.8.1, yet most cases remain mild, hospitalizations stay low, and no unknown pathogens or high-virulence strains have been detected by CDC or China CDC monitoring. Population immunity from prior infections and vaccination continues to limit severe outcomes. Realistic shifts could arise from a novel zoonotic spillover or a variant with substantial immune escape and heightened transmissibility, though current genomic data and model projections indicate these thresholds remain unlikely before year-end.